diaTribe Musings - T1D Management: Revolutionized but Challenges Remain

T1D Management: Revolutionized, but Challenges Remain
Wednesday, July 24, 2024
Virtual Event
Advances in technology – particularly continuous glucose monitors and automated insulin delivery systems – are revolutionizing diabetes management and helping people with T1D monitor, understand and more intentionally manage their diabetes. But anyone living with or caring for a loved one with T1D knows that the battle is far from won and significant challenges remain – ranging from tech challenges, skin irritations, hormonal issues, to the 24/7 mental burden of diabetes.
Watch this expert panel discussion featuring clinicians, researchers and individuals living with T1D to learn what needs more attention and what what we can do to make our lives easier.
PANELISTS

Philly De Piante
Director for International Insights,
dQ&A - The Diabetes Research CompanyAssociate Medical Director, Abbott Diabetes Care Business
Philly De Piante serves as the Director of International Insights for dQ&A, a diabetes research organization. Philly’s connection to dQ&A came after being diagnosed at age 17 and becoming involved in local and national advocacy efforts. She graduated Summa Cum Laude from the University of North Carolina at Charlotte and while in college, she interned at what was formerly JDRF - now Breakthrough T1D. Prior to joining dQ&A in 2017, she founded the Charlotte College Diabetes Network chapter and served as Chair of the Charlotte Type 1 Teens. Her background in Marketing and Italian and her personal connection to diabetes drive her work for dQ&A to offer a deep understanding of the lived experience with diabetes at a global level. Her goal is to connect those who live with diabetes and care for those with diabetes to the organizations that serve them. In her free time, Philly enjoys weightlifting, yoga, solo traveling, and geeking out to all things health and wellness.

Dr. Osagie Ebekozien, MD, MPH
Chief Medical Officer, T1D Exchange
Dr. Ebekozien currently serves as T1D Exchange’s Chief Medical Officer based in Boston, United States. In this role, he leads the T1D Exchange Quality Improvement Collaborative (T1DX-QI), having overseen its growth from 10 type 1 diabetes centers when he joined the organization to now 62 diabetes centers across the United States. He also led the establishment of the Type 2 diabetes collaborative (T2DX-Q1) and has grown it to 10 centers. He also serves as an Adjunct Professor of Population Health at the University of Mississippi Medical Center, where he teaches graduate level courses. Dr. Ebekozien's research interest is in advancing diabetes outcomes and equity. He has served as the Principal Investigator on multiple multi-center grants. He is a recipient of several awards including the 2022 Eli Lilly Leonard Award (Research) and the 2021 ISPAD International Pediatric Diabetes Innovation Award. He has co-authored numerous manuscripts on diabetes related topics in high impact journals and serves on the editorial board of several diabetes journals. He also recently edited a global text book on Type 1 Diabetes published by Endocrinology Clinics of North America/Elsevier. He is a frequent speaker at diabetes professional conferences and his work has been featured by multiple media networks.

Prof. Jennifer Sherr, MD, PhD
Professor of Pediatrics, Pediatric Endocrinology,
Yale University School of Medicine
Dr. Jennifer Sherr was determined to become a pediatric endocrinologist since the time of her diagnosis with Type 1 Diabetes in 1987. While she always wanted to care for those with T1D, her eyes were opened to the meaningful impact that clinical research has. Dr. Sherr has since been devoted to clinical research for over 15 years. She serves as a Professor in the Department of Pediatrics at Yale and focuses on methods, including new technologies and therapeutics, to improve the lives of all people living with diabetes.
MODERATOR

Julie Heverly
Senior Director, Time in Range Coalition
The diaTribe Foundation
As a Senior Director at the diaTribe Foundation, Julie brings more than 15 years of leadership in the diabetes ecosystem and 26 years of patient experience to her work with the Time in Range Coalition. Diagnosed with type 1 diabetes after her junior year at Washington & Jefferson College, Julie went on to provide public affairs and PR counsel to clients like the Eisenhower Presidential Museum, The National Center for Victims of Crime and Americans for Alaska. She eventually earned a position at Burson Marsteller, where she consulted a Fortune 500 company on government and community affairs. In 2006, Julie accepted her first staff position with the American Diabetes Association as Market Director in Richmond, VA. She oversaw some of the country’s most successful ADA campaigns during her decade of service in Philadelphia, as Director of Development and as Executive Director in Western PA and Eastern Ohio. Julie is the 2023 Lilly Leonard Award winner for patient advocacy. Julie and her husband, Steve, reside outside Pittsburgh, PA with their daughter, Vivian.